Delivery Order SPE2DB20D2002-SPE2DB25FL51Z
Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,520.28 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This firm fixed-price contract, with an ultimate completion date of August 27, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a delivery order valued at $6,481.97 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, with an ultimate completion date of May 5, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. Zepbound is a GLP-1 receptor agonist used for chronic weight management,...
- The Defense Logistics Agency awarded a delivery order valued at $11,288.84 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on October 31, 2025, with completion targeted for November 3, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting...
- The Defense Logistics Agency awarded a $13,150.18 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $14,976.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $2,971.10 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections, valued at $6,035.72. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist...
- The Defense Logistics Agency awarded a $5,621.91 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with an ultimate completion date of September 17, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,836.29 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $23,996.70 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which is classified as a child contract with no set-aside designation, has an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication...